Search Results - D. Morillo

426 | EPCORITAMAB+GEMOX LEADS TO HIGH MRD‐NEGATIVITY RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: AN UPDATED LONGITUDINAL MRD ANALYSIS by K. Karagoz, M. Wielgos‐Bonvallet, J. Karavitis, J. R. Harris, D. Belada, D. Morillo, U. Vitolo, S. D. Vindeløv, M. Risum, T. Ahmadi, M. Fereshteh, E. Szafer‐Glusman, D. Soong, M. Jure‐Kunkel, A. J. Steele

Get full text

104 | A GLOBAL PHASE 1B STUDY OF JNJ‐90014496, A CD19/CD20 BI‐SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY, IN RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL)... by K. Patel, J. M. Rhodes, L. Mountjoy, J. H. Christensen, M. Hutchings, P. Shaughnessy, N. Farhadfar, C. Tam, J. H. Baird, A. Ramakrishnan, M. Jak, K. Dorritie, A. Barraclough, D. Morillo, Y. Serroukh, M. Schwede, A. Abdulgawad, L. Magnano, M. O'Reilly, J. Kuruvilla, Y. Koh, U. Farooq, W. S. Kim, J. Bussolari, M. Beelen, J. S. Larsen, M. Suraneni, J. Wu, L. Slaets, A. Perales‐Puchalt, A. Banerjee, M. Ku

Get full text